1. Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features
   Sabino Russi et al, 2019, Cancers CrossRef
2. MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non‑cancerous tissues
   Yuan Liang et al, 2021, Oncology Letters CrossRef
3. Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5‑FU chemotherapy by blocking the carcinogenic effect of YY1
   Shan Liang et al, 2022, Experimental and Therapeutic Medicine CrossRef
4. Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
   Hélène Poinot et al, 2024, OncoImmunology CrossRef
5. Steroid sulfatase inhibitors: the current landscape
   Hanan S. Anbar et al, 2021, Expert Opinion on Therapeutic Patents CrossRef
6. Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer
   Yajing Feng et al, 2019, Gene CrossRef
7. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods
   Kechao Nie et al, 2020, Minerva Medica CrossRef
8. Comprehensive analysis of histone modification‑associated genes on differential gene expression and prognosis in gastric cancer
   Xiangyu Meng et al, 2019, Experimental and Therapeutic Medicine CrossRef
9. Profiling of Steroid Metabolic Pathways in Human Plasma by GC-MS/MS Combined with Microwave-Assisted Derivatization for Diagnosis of Gastric Disorders
   Wonwoong Lee et al, 2021, International Journal of Molecular Sciences CrossRef
10. Screening of Active Components and Key Targets of Radix Codonopsis in the Treatment of Gastric Cancer
    Lijun Tang et al, 2021, Journal of Chemistry CrossRef
11. Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer
    Juan‐Cheng Yang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef